Standing Order
All companies

Biotech

Recursion Pharmaceuticals, Inc.

RXRXNASDAQpure-play
Market cap$1.9B
Conviction3/ 5
HQSalt Lake City, Utah, USA

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Price · 180d

$3.59

-17.7%

Thesis

Recursion Pharmaceuticals runs an industrialized, automated biology platform that generates large datasets to train machine-learning models for drug discovery. Its scale and pharma partnerships aim to convert data advantages into a clinical pipeline.

Catalysts

  • Clinical-stage program readouts
  • Partnership milestone and option payments
  • Demonstrating platform-driven pipeline productivity

Not financial advice — research and opinion only. Disclosures